A pioneer in improved stroke outcomes
An esteemed neurologist, professor, and clinical epidemiologist at the University of Calgary, Michael D. Hill, MD, is internationally recognized for his pioneering contributions to stroke treatment. His novel clinical trials and research have set new standards for effective care and treatment of strokes, 85% of which are ischemic. Among his many achievements, Dr. Hill co-led the groundbreaking ESCAPE trial, demonstrating the effectiveness of endovascular thrombectomy (EVT) for removing large blood clots that cause the most severe ischemic strokes. This pivotal study reshaped therapeutic outcomes, as it showed that the use of EVT drastically reduced stroke-related disability and death. Since its publication in 2015, the ESCAPE study has informed clinical guidelines globally. The implementation of its results has changed the lives of millions of patients. Beyond his research, Dr. Hill is a prolific clinician-scientist, lecturer, and mentor, having supervised more than 150 students and fellows who have gone on to advance stroke care in other provinces and countries. Through his focus on innovative, patient-centred research and care, Dr. Hill has revolutionized the treatment of ischemic stroke, advancing the field of neurology and offering new hope for stroke patients of all ages.
About the CMHF
The Canadian Medical Hall of Fame (CMHF) celebrates Canadian heroes whose work advances health in Canada and the world, fostering future generations of health professionals through the delivery of local and national youth education programs and awards.
This enduring tribute to our country’s rich medical history is showcased here and in our physical exhibit hall in London, ON
